Garry E Menzel's Net Worth
$40.3 Thousand
Who is Garry E Menzel?
Garry E Menzel does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include DAVITA HEALTHCARE PARTNERS INC., Stoke Therapeutics, Inc., TCR2 THERAPEUTICS INC., Black Diamond Therapeutics, Inc., Regulus Therapeutics Inc., and Adaptimmune Therapeutics PLC.
SEC CIK
Garry E Menzel's CIK is 0001556064
Past Insider Trading and Trends
2022 was Garry E Menzel's most active year for acquiring shares with 15 total transactions. Garry E Menzel's most active month to acquire stocks was the month of November. 2022 was Garry E Menzel's most active year for disposing of shares, totalling 16 transactions. Garry E Menzel's most active month to dispose stocks was the month of May. 2021 saw Garry E Menzel paying a total of $276,079.13 for 698,479 shares, this is the most they've acquired in one year. In 2023 Garry E Menzel cashed out on 1,382,656 shares for a total of $43,446.98, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
DAVITA HEALTHCARE PARTNERS INC. (DVA) Snapshot price: $149.98
Senior Vice President, Finance
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 9
| |||
| No matching records found | |||||||||
Stoke Therapeutics, Inc. (STOK) Snapshot price: $14.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TCR2 THERAPEUTICS INC. No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -404.33K |
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
| -18.70% | -31.94K |
$1.10 | -$35,033.87 | 138.87K |
Scheduled
|
Dec 9 - Dec 13
| ||
Form 4
| -9.74% | -18.43K |
$1.27 | -$23,360.06 | 170.81K |
Scheduled
|
Dec 7 - Dec 8
| ||
Form 4
| -11.01% | -23.42K |
$1.36 | -$31,784.37 | 189.23K |
Scheduled
|
Dec 5 - Dec 6
| ||
Form 4
|
∞
| 212.65K |
$1.39 | -$11,687.12 | 212.65K |
Scheduled
|
Dec 1 - Dec 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
| 265.46K |
Jul 5
| |||
Form 4
| +0.79% | 1.43K |
$2.30 | $3,277.50 | 180.93K |
Feb 28
| |||
Form 4
| +4,294.30% | 175.42K |
$0.77 | $135,517.72 | 179.51K |
Aug 31 - Dec 10
| |||
Form 4
| +80.19% | 1.82K |
$12.37 | $22,492.34 | 4.08K |
Aug 31 - Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
|
∞
| 2.27K |
$11.25 | $25,493.70 | 2.27K |
Aug 30 - Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Black Diamond Therapeutics, Inc. (BDTX) Snapshot price: $5.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 20
| |||
Form 4
|
∞
| 51.83K |
—
|
—
| 51.83K |
Feb 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Regulus Therapeutics Inc. (RGLS) Snapshot price: $1.48
COO & Executive VP, Finance
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||